Anders Ellern Bilgrau PhD
Principal Statistician, Novo Nordisk He holds both a PhD and a master’s degree in Biostatistics through a joint fellowship at the Institute of Mathematical Sciences, Aalborg University, and the Department of Haematology, Aalborg University Hospital.
About this speaker
Currently at Novo Nordisk, Anders Ellern Bilgrau is focused on developing advanced cloud-based, high-performance computing environments for R and Python, tailored for clinical analysis. This work encompasses building and managing everything from essential packages to the infrastructure itself. While officially titled "statistician," [Your Name]'s role more accurately aligns with software development and data engineering due to the technical nature of the projects.
Returning to Novo Nordisk after a stint as the sole Data Scientist at Seluxit, an IoT company, Anders Ellern Bilgrau handled end-to-end data science processes, from creating "analytics APIs" and data wrangling to model deployment, data analysis, and visualization. This role focused on extracting actionable insights from data to deliver meaningful value to Seluxit and its clients.
Earlier in his career at Novo Nordisk, Anders Ellern Bilgrau contributed as a statistician to the design, analysis, and reporting of Phase I and III clinical trials for anti-obesity drugs, where he was instrumental in promoting the use of the R programming language in pharmaceutical applications—a key reason for his return to the company.
His research focused on high-dimensional biological data and gene network estimation, particularly the reproducibility of biological experiments.
